Previous studies in ulcerative colitis have demonstrated that blocking IL-1R2 upregulated the expression of pro-inflammatory chemokines induced by Il-1β, such as TNF-a, IL-6 and IFN-γ [34]. This evidence concerns the gene IFNG and ulcerative colitis.